<DOC>
	<DOCNO>NCT01434615</DOCNO>
	<brief_summary>The purpose study ( ) characterize current management patient systolic heart failure ( HF ) South Asia follow educational intervention current guideline delivery disease management tool ( b ) characterize effect current therapy clinical outcome patient manage tertiary care center across South Asia . Current therapy include characterization post market performance market release Medtronic cardiac resynchronization therapy ( CRT ) cardiac resynchronization therapy plus implantable cardiac defibrillator ( CRT-D ) system cardiac resynchronization therapy ( CRT ) .</brief_summary>
	<brief_title>Medtronic South Asian Systolic Heart Failure Registry</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>Patient sign date study inform consent . Patients moderate severe heart failure ( NYHA Class III IV ) EF &lt; 35 % measure echo , MUGA , contrast ventriculogram MRI . QRS duration &gt; 120 m . Patient life expectancy le 12 month due medical condition HF . Patient experience unstable angina , acute myocardial infarction ( MI ) , coronary artery bypass graft ( CABG ) percutaneous transluminal coronary angioplasty ( PTCA ) within past 3 month . Patient know chronic permanent atrial arrhythmia ( i.e. , case longstanding atrial fibrillation great 1 year , include cardioversion indicate attempt ) . Patient enrol concurrent study would confound result study . Patient pregnant breastfeeding . Patient CRT device implant previously . Patient heart transplant .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Moderate advance</keyword>
	<keyword>patient</keyword>
	<keyword>current consensus guideline</keyword>
</DOC>